Changes in the clinical features of amyotrophic lateral sclerosis in rural Japan

Internal Medicine

Volumn 52, Issue 15, 2013, Pages 1691-1696

  Furuta, Natsumi ^a   Makioka, Kouki ^a   Fujita, Yukio ^a   Okamoto, Koichi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Age at onset; ALS; Clinical features; Frontotemporal lobar degeneration; Initial symptoms

Indexed keywords

ADULT; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY;

AGE FACTORS; AGE OF ONSET; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ASIAN CONTINENTAL ANCESTRY GROUP; DISEASE PROGRESSION; FEMALE; HUMANS; INPATIENTS; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RURAL POPULATION;

EID: 84881004620     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.0195     Document Type: Article

References (35)

1. Eisen A. Amyotrophic lateral sclerosis. Intern Med 34: 824-832, 1995.
2. Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol 19: 360-375, 2012.
3. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 377: 942-955, 2011.
4. Ringel SP, Murphy JR, Alderson MK, et al. The natural history of amyotrophic lateral sclerosis. Neurology 43: 1316-1322, 1993.
5. Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol 253: 1428-1436, 2006.
6. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 293-299, 2001.
7. Rosen AD. Amyotrophic lateral sclerosis. Clinical features and prognosis. Arch Neurol 35: 638-642, 1978.
8. Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: a 10-year prospective populationbased study. Neurology 72: 725-731, 2009.
9. Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology 55: 1262-1266, 2000.
10. Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology 71: 1889-1895, 2008.
11. Fang F, Valdimarsdottir U, Bellocco R, et al. Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol 66: 515-519, 2009.
12. Neilson S, Robinson I, Nymoen EH. Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966-1989: evidence for a susceptible subpopulation. J Neurol Sci 122: 148-154, 1994.
13. Neilson S, Gunnarsson LG, Robinson I. Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation. J Neurol 241: 448-455, 1994.
14. Neilson S, Gunnarsson LG, Robinson I. Rising mortality from motor neurone disease in Sweden 1961-1990: the relative role of increased population life expectancy and environmental factors. Acta Neurol Scand 90: 150-159, 1994.
15. McGuire V, Longstreth WT Jr, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 47: 571-573, 1996.
16. Piano YS, Wakabayashi K, Kakita A, et al. Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol 13: 10-22, 2003.
17. Shimohata T, Yanagawa K, Tanaka K, Nishizawa M. Longitudinal analysis of age at onset and initial symptom of patients with amyotrophic lateral sclerosis. Rinsho Shinkeigaku (Clin Neurol) 46: 377-380, 2006 (in Japanese, Abstract in English).
18. Terao S, Miura N, Osano Y, Adachi K, Sobue G. Clinical characteristics of elderly Japanese patients with amyotrophic lateral sclerosis; with special reference to the development of respiratory failure. Rinsho Shinkeigaku (Clin Neurol) 46: 381-389, 2006 (in Japanese, Abstract in English).
19. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a populationbased study. Arch Neurol 57: 1171-1176, 2000.
20. Zoccolella S, Beghi E, Palagano G, et al. Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy. Eur J Neurol 13: 789-792, 2006.
21. Forbes RB, Colville S, Swingler RJ. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. Age Ageing 33: 131-134, 2004.
22. O'Toole O, Traynor BJ, Brennan P, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 79: 30-32, 2008.
23. Atsuta N, Watanabe H, Ito M, et al. Age at onset influence on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J Neurol Sci 276: 163-169, 2009.
24. Loureiro MP, Gress CH, Thuler LC, Alvarenga RM, Lima JM. Clinical aspects of amyotrophic lateral sclerosis in Rio de Janeiro/ Brazil. J Neurol Sci 316: 61-66, 2012.
25. Atsuta N, Nakamura R, Watanabe H, et al. JaCALS: a prospective multicenter ALS cohort study. Rinsho Shinkeigaku (Clin Neurol) 51: 903-905, 2011 (in Japanese, Abstract in English).
26. http://www.nanbyou.or.jp. Japan Intractable Diseases Research Foundation/Japan Intractable Diseases Information Center. Recipients of specified disease treatment. 2012 (in Japanese).
27. Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351: 602-611, 2006.
28. Ishihara T, Ariizumi Y, Shiga A, et al. FTLD/ALS as TDP-43 proteinopathies. Rinsho Shinkeigaku (Clin Neurol) 50: 1022-1024, 2010 (in Japanese, Abstract in English).
29. Amador-Ortiz C, Lin WL, Ahmed Z, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61: 435-445, 2007.
30. Kukull WA, Higdon R, Bowen JD, et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 59: 1737-1746, 2002.
31. http://www8.cao.go.jp/kourei/english/annualreport/index-wh.html. Cabinet Office Japan. Annual Report on the Aging Society, 2010.
32. http://www.mhlw.go.jp/english/wp/wp-hw5/01.html. Ministry of Health, Labour and Welfare. White Papers & Reports. Annual Health, Labour and Welfare Report, 2011.
33. Lillo P, Garcin B, Hornberger M, Bak TH, Hodges JR. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol 67: 826-830, 2010.
34. Bak TH, Hodges JR. The effects of motor neurone disease on language: further evidence. Brain Lang 89: 354-361, 2003.
35. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60: 1094-1097, 2003.